Foghorn Therapeutics Inc. (FHTX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Foghorn Therapeutics Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FHTX
Foghorn Therapeutics Inc.
$1.93HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.79HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — FHTX vs LENZ
growth of $100 · dividends reinvested · last 5yFHTX -80.6% (-27.9%/yr)LENZ -91.4% (-38.7%/yr)FHTX compounded faster over this window
FHTX LENZ
FHTX vs LENZ: by the numbers
- •LENZ is the larger company ($119M vs $113M market cap).
- •Both run net losses; FHTX's is the smaller (-175.78% vs -586.74% net margin).
Metrics side by side
Valuation
| Metric | FHTX | LENZ |
|---|---|---|
| P/S ratio | 3.08 | 5.53 |
| P/B ratio | N/A | 0.54 |
Profitability
| Metric | FHTX | LENZ |
|---|---|---|
| Gross margin | 89.22% | 90.14% |
| Operating margin | -265.64% | -477.46% |
| Net margin | -175.78% | -586.74% |
| ROE | N/A | -57.47% |
| ROIC | -44.81% | -61.84% |
Growth (annualized)
| Metric | FHTX | LENZ |
|---|---|---|
| Revenue CAGR (5Y) | 105.83% | N/A |
| Total return CAGR (5Y) | -31.87% | -35.49% |
Frequently asked
- How have FHTX and LENZ total returns compared?
- Over the past 5 years, FHTX delivered -31.87% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Foghorn Therapeutics ROELENZ Therapeutics ROEFoghorn Therapeutics operating marginLENZ Therapeutics operating marginFoghorn Therapeutics revenue growthLENZ Therapeutics revenue growthFoghorn Therapeutics free cash flowLENZ Therapeutics free cash flow
Foghorn Therapeutics & LENZ Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.